Ifp Advisors, Inc Gsk PLC Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$16.13 - $44.61 $1,096 - $3,033	-68 Reduced 0.6%	11,173 $521,000
Q2 2022 Sep 06, 2022	BUY	$42.05 - $47.77 $472,684 - $536,982	11,241 New	11,241 $520,000
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $472,684 - $536,982	-11,241 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$40.23 - $47.74 $178,057 - $211,297	4,426 Added 64.94%	11,241 $499,000
Q1 2022 Aug 08, 2022	BUY	$40.23 - $47.74 $59,218 - $70,273	1,472 Added 27.55%	6,815 $302,000
Q4 2021 Jan 12, 2022	BUY	$38.88 - $45.31 $10,031 - $11,689	258 Added 5.07%	5,343 $238,000
Q3 2021 Oct 06, 2021	BUY	$38.79 - $43.16 $6,788 - $7,552	175 Added 3.56%	5,085 $194,000
Q2 2021 Jul 13, 2021	SELL	$36.52 - $41.46 $3,871 - $4,394	-106 Reduced 2.11%	4,910 $194,000
Q1 2021 Apr 30, 2021	SELL	$34.27 - $40.01 $20,013 - $23,365	-584 Reduced 10.43%	5,016 $180,000
Q4 2020 Jan 25, 2021	SELL	$34.07 - $39.94 $10,629 - $12,461	-312 Reduced 5.28%	5,600 $206,000
Q3 2020 Oct 29, 2020	BUY	$38.11 - $42.99 $10,556 - $11,908	277 Added 4.92%	5,912 $225,000
Q2 2020 Aug 05, 2020	SELL	$37.87 - $43.58 $10,755 - $12,376	-284 Reduced 4.8%	5,635 $229,000
Q1 2020 May 12, 2020	SELL	$32.47 - $48.83 $58,705 - $88,284	-1,808 Reduced 23.4%	5,919 $220,000
Q4 2019 Jan 17, 2020	SELL	$42.0 - $48.25 $51,156 - $58,768	-1,218 Reduced 13.62%	7,727 $363,000
Q3 2019 Nov 07, 2019	BUY	$40.46 - $43.52 $53,164 - $57,185	1,314 Added 17.22%	8,945 $377,000
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $979,793 - $1.08 Million	-25,403 Reduced 76.9%	7,631 $316,000
Q4 2018 Jan 23, 2019	SELL	$37.8 - $42.69 $164,430 - $185,701	-4,350 Reduced 11.64%	33,034 $1.29 Million
Q3 2018 Oct 25, 2018	BUY	$39.75 - $42.69 $452,673 - $486,153	11,388 Added 43.81%	37,384 $0
Q2 2018 Aug 07, 2018	SELL	$39.61 - $42.76 $54,107 - $58,410	-1,366 Reduced 4.99%	25,996 $0
Q1 2018 Jun 03, 2019	BUY	$36.18 - $40.15 $36,433 - $40,431	1,007 Added 3.82%	27,362 $971,000
Q1 2018 May 09, 2018	SELL	$36.18 - $40.15 $36,433 - $40,431	-1,007 Reduced 3.68%	26,355 $0
Q4 2017 Jan 24, 2018	SELL	$35.34 - $41.9 $504,690 - $598,373	-14,281 Reduced 34.29%	27,362 $0
Q3 2017 Oct 30, 2017	SELL	$39.44 - $41.55 $53,046 - $55,884	-1,345 Reduced 3.13%	41,643 $1.69 Million
Q2 2017 Jun 03, 2019	BUY	N/A	2,147 Added 5.26%	42,988 $1.85 Million
Q1 2017 Jun 03, 2019	BUY	N/A	1,280 Added 3.24%	40,841 $1.72 Million
Q4 2016 Jun 03, 2019	BUY	N/A	8,019 Added 25.42%	39,561 $1.52 Million
Q2 2016 Jun 03, 2019	BUY	N/A	23,911 Added 313.34%	31,542 $1.37 Million
Q1 2016 Jun 03, 2019	BUY	N/A	7,631	7,631 $316,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account